WASHINGTON--In an alarming trend, top selling drugs are being pulled from pharmacies after researchers find new, and often fatal, side effects.
Since 1997, 11 popular prescription drugs have been recalled by the Food and Drug Administration (FDA) after causing deaths or serious injuries. Two weeks ago, Lotronex became the latest to be taken off the market for a reported intestinal side effect. It had been on the shelves for nine months.
Although the FDA, under congressional pressure, has sped up the approval process for new drugs, it is not willing to take all the blame. Officials with the administration say that doctors should be paying more attention. Too often doctors are ignoring, or just not reading warning labels.
Doctors counter that the FDA is not appropriately testing new drugs before releasing them to the public. Every medication is tested on a few hundred to a few thousand patients. There are 82 workers who track the side effects once these drugs reach the market. With such a small pool of test patients and researchers, the FDA often has to sit back and wait to see what side effects occur when millions of Americans start using a new prescription.
If a problem arises, the FDA tries to issue warnings, but they often go unheeded. For two years, the administration warned that heartburn drug Propulsid should not be prescribed to people with kidney or heart disease. However, the warning was ignored and the drug was taken off shelves last summer after a reported 80 people died.
The FDA and doctors agree that patients should ask more questions about new prescription drugs. Patients should also be cautious about taking drugs that have not been on the market for more than a year. Most side effects are spotted within the first year of sale.
Information from www.latimes.com
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.